OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Dual organ transplantation: Pancreas and Liver in the kidney axis	49
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	34
Editorial introductions	33
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	31
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	28
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	27
Interferon gamma in the pathogenesis of hypertension − recent insights	23
Maximizing opportunities for kidney transplantation in older adults	21
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	20
The impact of conflicts on patients with chronic kidney disease	19
Microvascular inflammation in the kidney transplant, beyond acute antibody-mediated rejection	18
Evolution in the targets for blood pressure treatment	17
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	17
Modern indications for referral for kidney and pancreas transplantation	16
Editorial introduction	16
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	15
Prediction models for earlier stages of chronic kidney disease	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	15
Renal denervation for the treatment of hypertension and kidney disease	14
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	13
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	13
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	13
Plant-based diets for kidney disease prevention and treatment	13
International equity in access to home dialysis	13
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	13

Updates in tolerance: future directions to improve kidney allograft survival	12
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	12
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	12
Hypertension guidelines need to be patient oriented	12
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	12
Built environment and chronic kidney disease: current state and future directions	12
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	12
Bringing the end-stage kidney disease life plan home	12
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	11
Understanding renal phosphate handling: unfinished business	11
The race coefficient in glomerular filtration rate-estimating equations and its removal	11
Complement detection in kidney biopsies – utility and challenges	11
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	11
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	11
Editorial: One size does not fit all: moving toward individualized therapy	11
Lipocalin-2: a novel link between the injured kidney and the bone	10
Stopping renin–angiotensin–aldosterone system inhibitors in kidney disease	10
Editorial introductions	10
Combination therapy with kidney protective therapies: optimizing the benefits?	10
A guide for program development of environmentally sustainable kidney care	10
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	10
New advances in the diagnosis and pathologic spectrum of monoclonal gammopathy of renal significance	10
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	10
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	10
Editorial introductions	9
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
When the earth shakes unexpectedly: impact on nephrology services and patients	9
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	8
Cancer drugs and acute kidney injury: new therapies and new challenges	8
Deep learning applications for kidney histology analysis	8
Implications of the cystatin C/creatinine discordance	8
Climate change and kidney stones	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	8
The current therapeutic approach for anaemia after kidney transplant	8
Automation and innovation in home hemodialysis machines	8
Paracellular transport along the nephron in physiology and pathophysiology	8
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	8
Update on antineutrophil cytoplasmic antibody vasculitis: Erratum	8
Renal osteodystrophy: something old, something new, something needed	7
Recent advances in treatment options for kidney disease	7
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	7
Sex differences in renal electrolyte transport	7
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	7
C3 glomerulopathy: advancements in diagnostics and therapeutics	7
Prospects for gene therapy in polycystic kidney disease	7
Editorial introduction	7
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	7
Editorial introductions	7
New and old approaches to nutritional management of acute and chronic glomerulonephritis	7

New insights into renal calcium-sensing receptor activation	7
Impact of intensive blood pressure control on kidney outcomes	7
Renal denervation: recent developments in clinical and preclinical research	7
Editorial introductions	7
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
New guidelines and therapeutic updates for the management of lupus nephritis	6
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
The genetics of cystinuria – an update and critical reevaluation	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	6
The changing trajectory of diabetic kidney disease	6
Building kidney organoids from pluripotent stem cells	6
Early changes in kidney function in young adults: what is the significance?	6
An update on the epidemiology of chronic kidney disease of uncertain etiology	6
Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges	6
Staff-assisted peritoneal dialysis in the United States: from evidence to national adoption	6
Novel approaches in antihypertensive pharmacotherapeutics	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Peritoneal dialysis and heart failure	6
Evolving indications and management patterns in heart – kidney transplantation	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6